Literature DB >> 30343402

Proteinuria is an independent predictor of rapid progression of mild to moderate aortic stenosis in patients with preserved renal function.

You-Jung Choi1, Jun-Bean Park2,3,4, In-Chang Hwang5, Seung-Pyo Lee1,6, Hyung-Kwan Kim1,6, Yong-Jin Kim1,6, Dae-Won Sohn1,6.   

Abstract

Although proteinuria is a well-known risk factor for cardiovascular disease, its relationship with the progression of aortic stenosis (AS) has not been established. Our aim was to investigate the relationship between proteinuria (detected by urine dipstick test) and AS progression (assessed by the annualized reduction rate of aortic valve area [AVA]). A total of 460 patients with mild to moderate AS (defined by a peak velocity of 2.0-4.0 m/s) without end-stage renal disease who underwent two echocardiograms at least 3 months apart were included. The progression of AS was significantly faster in patients with proteinuria than those without (108 patients vs. 352 patients; annualized reduction rate of AVA, - 7.7 ± 13.5% vs. - 4.5 ± 11.6%; p = 0.017). The relationship between the presence of proteinuria and the accelerated progression of AS was significant among patients with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 (- 11.0 ± 17.5% vs. - 4.2 ± 10.0%; p < 0.001), but not among those with eGFR 15-60 mL/min/1.73 m2 (- 5.8 ± 10.3 vs. - 5.3 ± 14.8%; p = 0.822). When stratified by the presence of diabetes, the association of proteinuria with AS progression was only significant in patients without diabetes (- 8.1 ± 12.0% vs. - 8.1 ± 15.7%; p = 0.018). Multivariable logistic regression analysis identified that the presence of proteinuria was an independent predictor of AS progression. The progression of AS was accelerated in patients with mild to moderate AS and proteinuria, particularly among those with preserved renal function and no diabetes.

Entities:  

Keywords:  Aortic stenosis; Aortic valve area; Proteinuria

Mesh:

Substances:

Year:  2018        PMID: 30343402     DOI: 10.1007/s10554-018-1473-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  34 in total

Review 1.  Calcification of the aortic valve in the dialyzed patient.

Authors:  Gérard M London; Bruno Pannier; Sylvain J Marchais; Alain P Guerin
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

2.  New insights into the progression of aortic stenosis: implications for secondary prevention.

Authors:  S Palta; A M Pai; K S Gill; R G Pai
Journal:  Circulation       Date:  2000-05-30       Impact factor: 29.690

Review 3.  Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Authors:  Rosario V Freeman; Catherine M Otto
Journal:  Circulation       Date:  2005-06-21       Impact factor: 29.690

4.  Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis.

Authors:  Takahiro Ohara; Yuji Hashimoto; Akihiko Matsumura; Makoto Suzuki; Mitsuaki Isobe
Journal:  Circ J       Date:  2005-12       Impact factor: 2.993

5.  Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study.

Authors:  J Jiménez-Candil; J Bermejo; R Yotti; C Cortina; M Moreno; J L Cantalapiedra; M A García-Fernández
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

6.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

7.  Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

Authors:  Kevin D O'Brien; Jeffrey L Probstfield; Michael T Caulfield; Khurram Nasir; Junichiro Takasu; David M Shavelle; Audrey H Wu; Xue-Qiao Zhao; Matthew J Budoff
Journal:  Arch Intern Med       Date:  2005-04-25

Review 8.  Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.

Authors:  Raphael Rosenhek; Florian Rader; Nicole Loho; Harald Gabriel; Maria Heger; Ursula Klaar; Michael Schemper; Thomas Binder; Gerald Maurer; Helmut Baumgartner
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

9.  Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography.

Authors:  Raphael Rosenhek; Ursula Klaar; Michael Schemper; Christine Scholten; Maria Heger; Harald Gabriel; Thomas Binder; Gerald Maurer; Helmut Baumgartner
Journal:  Eur Heart J       Date:  2004-02       Impact factor: 29.983

10.  Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.

Authors:  Kevin D O'Brien; David M Shavelle; Michael T Caulfield; Thomas O McDonald; Katherine Olin-Lewis; Catherine M Otto; Jeffrey L Probstfield
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.